Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
- 30 April 1999
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 33 (5) , 1163-1173
- https://doi.org/10.1016/s0735-1097(99)00025-x
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitorsLife Sciences, 1997
- Double‐Blind Comparison of Losartan, Lisinopril, and Metolazone in Elderly Hypertensive Patients with Previous Angiotensin‐Converting Enzyme Inhibitor‐Induced CoughThe Journal of Clinical Pharmacology, 1997
- Valsartan, a New Angiotensin II Receptor Antagonist: A Double‐Blind Study Comparing the Incidence of Cough with Lisinopril and HydrochlorothiazideThe Journal of Clinical Pharmacology, 1997
- Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failureAmerican Heart Journal, 1996
- Angiotensin‐Converting Enzyme Inhibitors and Cough: A Prospective Evaluation in Hypertension and in Congestive Heart FailureThe Journal of Clinical Pharmacology, 1994
- Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.Heart, 1993
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic ExerciseCirculation, 1974